<SEC-DOCUMENT>0001213900-20-042915-index.html : 20201216
<SEC-HEADER>0001213900-20-042915.hdr.sgml : 20201216
<ACCEPTANCE-DATETIME>20201216090707
ACCESSION NUMBER:		0001213900-20-042915
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20201216
FILED AS OF DATE:		20201216
DATE AS OF CHANGE:		20201216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PolyPid Ltd.
		CENTRAL INDEX KEY:			0001611842
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38428
		FILM NUMBER:		201391401

	BUSINESS ADDRESS:	
		STREET 1:		20 HAMAGSHIMIM STREET, MATALON CENTER
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			49348
		BUSINESS PHONE:		972-74-7195700

	MAIL ADDRESS:	
		STREET 1:		20 HAMAGSHIMIM STREET, MATALON CENTER
		CITY:			PETACH TIKVA
		STATE:			L3
		ZIP:			49348
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea131731-6k_polypid.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
Document 1 - file: ea131731-6k_polypid.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea131731ex99-1_polypid.htm
<DESCRIPTION>PRESS RELEASE ISSUED BY POLYPID LTD. ON DECEMBER 16, 2020, TITLED "POLYPID INITIATES SHIELD II: SECOND PHASE 3 CLINICAL TRIAL OF D-PLEX100 FOR THE PREVENTION OF POST-ABDOMINAL SURGERY INCISIONAL INFECTIONS."
<TEXT>
Document 2 - file: ea131731ex99-1_polypid.htm

</DOCUMENT>
</SEC-DOCUMENT>